Relationship Between Self-reported Depression and Self-reported Visual Function in Latinos

Paz, Sylvia H.; Wu, Joanne; Azen, Stanley P.; Varma, Rohit

doi:10.1001/archopht.121.7.1021

Cited by 48 publications

(35 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…10,[26][27][28][29] Although a causeeffect relationship cannot be established in a cross-sectional study, it is plausible that people with visual impairment are more likely to have problems with functioning, which in turn leads to depression. In our case, the presence of depressive symptoms is more often seen in those elderly with worse visual function.…”

Section: Discussionmentioning

confidence: 99%

Visual Function Versus Visual Acuity in Older People

Hidalgo¹,

Martínez²,

Bravo³

et al. 2009

NOPE

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Visual Function Versus Visual Acuity in Older People

Hidalgo¹,

Martínez²,

Bravo³

et al. 2009

NOPE

View full text Add to dashboard Cite

show abstract

“…Other non-ocular factors that have been reported to influence NEI-VFQ-25 profiles include ethnicity, 16 income, 12 and individual factors such as coping or adaptation mechanisms. 14,18 Our study population was predominately white, hence the comparison of NEI-VFQ-25 profiles by ethnicity was not assessed.…”

Section: Discussionmentioning

confidence: 99%

“…2,9 The use of the NEI-VFQ-25 has been reported in a number of American population-based cohorts, including the Wisconsin Epidemiologic Study of Diabetic Retinopathy, 10 the Vision and Eye Research Project (Proyecto VER), 11,12 and the Los Angeles Latino Eye Study (LALES). 13,14 To date, however, its use has not been reported from any large Australian population-based sample. Hence, this report aims to assess vision-specific HRQOL and the impact of age-related visual impairment in a population-based sample of community-living older Australians using the self-administered NEI-VFQ-25.…”

Section: Introductionmentioning

confidence: 99%

Assessment of Vision-Related Quality of Life in an Older Population Subsample: The Blue Mountains Eye Study

Chia

Mitchell

Ojaimi

et al. 2006

Ophthalmic Epidemiology

View full text Add to dashboard Cite

The findings from this community-dwelling older population show that the NEI-VFQ-25 differentiates well between various levels of visual impairment with regard to the magnitude of their impact on vision-specific quality of life. Greater impacts were noted among persons with bilateral compared to unilateral impairment, with increasing impacts at greater severities of visual impairment. Visual impairment from refractive errors is more frequent than from underlying pathologic disorders, but the impact of correctable visual impairment was considerably milder than the impact of non-correctable visual impairment.

show abstract

“…It is the fourth major cause of disability worldwide [27] and a common side effect in people with vision loss [28][29][30][31][32][33]. Multiple studies have found close to a 30% prevalence rate of depression among elderly patients with advanced AMD, [27,34] and these patients are at an increased risk of suicide [35].…”

Section: Depressionmentioning

confidence: 99%

The Implantable Miniature Telescope and Quality of Life Improvements in Patients with End-Stage Age-Related Macular Degeneration

Primo¹

2017

J Community Med Health Educ

View full text Add to dashboard Cite

Age-related macular degeneration (AMD) is a progressive, degenerative eye disease that leads to central vision loss in people older than 60. End-stage AMD, for which there is no cure, is the leading cause of blindness in highincome countries. Often underappreciated by physicians, AMD is an important public health problem as patients can experience significant emotional distress, reduced cognitive function and a decrease in quality of life from depression, isolation, reduced mobility, and independence. These patients are more likely to suffer from falls and injuries, which may result in serious, life-threatening complications and significant medical costs. There are no medical interventions that can halt the visual outcome of end-stage AMD; patients can only make the best of the vision they have left through low-vision rehabilitation and external devices and tools. In 2010, the U.S. Food and Drug Administration approved the implantable miniature telescope (IMT; VisionCare Ophthalmic Technologies, Saratoga, CA) prosthesis for severely visually impaired patients with bilateral end-stage AMD. Patients with no other treatment options may have improved quality of life after implantation due to visual gains, increased mobility and independence, and improved overall function.

show abstract

Relationship Between Self-reported Depression and Self-reported Visual Function in Latinos

Cited by 48 publications

References 57 publications

Visual Function Versus Visual Acuity in Older People

Visual Function Versus Visual Acuity in Older People

Assessment of Vision-Related Quality of Life in an Older Population Subsample: The Blue Mountains Eye Study

The Implantable Miniature Telescope and Quality of Life Improvements in Patients with End-Stage Age-Related Macular Degeneration

Contact Info

Product

Resources

About